AI
| Followers | 843 |
| Posts | 122881 |
| Boards Moderated | 9 |
| Alias Born | 09/05/2002 |
Wednesday, January 09, 2008 1:36:20 AM
>Is IDX184 first-in-class?<
That depends on what the definition of class is
Seriously, I’m not aware of another HCV drug in development that’s a nucleotide prodrug with the properties that IDX184 has.
Read the table in #msg-25836105 and decide for yourself. Or, better yet, listen to the JPM webcast replay, which comes with very detailed slides.
That depends on what the definition of class is
Seriously, I’m not aware of another HCV drug in development that’s a nucleotide prodrug with the properties that IDX184 has.
Read the table in #msg-25836105 and decide for yourself. Or, better yet, listen to the JPM webcast replay, which comes with very detailed slides.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
